Glenda Ernst
Glenda Ernst
Assistant Professor
  • :(5411) 43096400

Department of Immunology
University of Buenos Aires
Argentina

Education

PhD - Pharmacy and Biochemistry School, Immunology 2009 - 2013
Molecular Biology 1994-2000

Biography

Ernst a Scientific Coordinator of British Hospital from Buenos Aires, Argentine. After graduating from University of Buenos Aires, she finished is post-graduate studies (PhD) and she was trained in a Respiratory Hospital (Hospital de Rehabilitación Respiratoria María Ferrer). She teaches immunology in University of Buenos Aires and she work as scientific coordinator at British Hospital.

Her studies are focused in airway inflammation, especially in patients with Interstitial Lung Diseases, COPD, Severe Asthma, and Pulmonary Alveolar Proteinosis. Currently she is working in clinical trials and basic protocols analyzing biomarkers in serum and sputum samples from COPD patients. Besides she is studying biomarkers in patients with Idiopathic Pulmonary fibrosis.

Research Interest

  • Non infectious lung diseases (COPD, ILD-IPF, and severe asthma)
  • Sleep apneas
  • Innate Immune Response

 

Professional Activities:

RoemmersFundation - Analysis of Biomarkers in Patients with Idiopathic Pulmonary Fibrosis. Study of its use as a potential end-point of treatment trials 2014-2016
Incentive award in health. Ministry of Health of the City of Buenos Aires 2015
Award for best research work in copd, cediquifa, for the work: Heterogeneity in inflammatory phenotypes of patients with COPD: Role of sputum differential cell count. 2015
Better original journal Award, published in Journal of American Respiratory Medicine: Inflammatory Cytokines in the Bronchoalveolar Lavage of Patients with Diffuse Interstitial Lung, Ernst et al RAMR 2014
Global case report Award - Chest Meeting, Atlanta, Georgia. (American College of Chest Physician). 2012
RIMA Award for Excellence in International Scientific Update. Gold Medal. Red of Informatics in Advance Medicine 2012 - 2015
Aquiles roncoroni Award - Chest Meeting, Honolulu, Hawaii. (American College of Chest Physician). 2011
Stimulation Award for Initiation to Scientific Research, Pharmacy and Biochemistry School, UBA. 2000
Leonardo satz Award (3° place) Argentine Society of Immunology. 2012
Konex-lalcec Award in Basic Research in Cancer 2009
Fiorini-lalcec Award in Basic Research in Cancer 2001

Publications

  1. Bilateral Bronchiectasis as a Presentation Form of Pulmonary Marginal Zone B-Cell Lymphoma of Bronchus Associated Lymphoid Tissue.Case Rep Oncol Med. 2015; 2015:975786.
  2. Histidine-rich glycoprotein and idiopathic pulmonary fibrosis.  Ernst G, Dantas E, Sabatté J, Caro F, Salvado A, Grynblat P and Geffner J.Respir Med. 2015 Dec;109(12):1589-91.
  3. Comparative Study between Sequential Automatic and Manual Home Respiratory Polygraphy Scoring Using a Three-Channel Device: Impact of the Manual Editing of Events to Identify Severe Obstructive Sleep Apnea. Glenda E, Bosio M, Salvado A, Nogueira F, Nigro C, and Borsini E.  Sleep Disorders (2015), 2015:314534. DOI: http://dx.doi.org/10.1155/2015/314534.
  4. Can CPAP be indicated in adult patients with suspected obstructive sleep apnea only on the basis of clinical data? C Nigro, E Dibur, MR Aragone, E Borsini, G Ernst, F Nogueria. Sleep and Breathing, 2015, en prensa (DOI: 10.1007/s11325-015-1202-2)
  5. Utility of the STOP-BANG components to identify sleep apnea using home respiratory polygraphy.Borsini E, Ernst G, Salvado A, Bosio M, Chertcoff J, Nogueira F, Nigro C. Sleep and Breathing, 2015, en prensa (DOI: 10.1007/s11325-015-1174-2)
  6. Tracheobronchial Tuberculosis without  Lung Involvement. Campos J, Ernst G, Borsini E, Garcia,  Blasco M, Bosio M and Salvado A. Journal of Clinical Medicine Research, 2015;7(8): 646-648.
  7. Neutrophils suppress γδ T-cell function. Sabbione F, Gabelloni L, Ernst G,  Gori S, Salamone G, Oleastro M,  Trevani A, Geffner J, Jancic C. European Journal of Immunology; 44(3):819-30, 2014.
  8. Inhibition of bronchoalveolar lavage hyaluronan release  by corticosteroid administration in a murine asthma model. Ernst G, Lompardía S, Cordo Russo R, Gentilini V, Venturiello S, Galíndez F, Grynblat P and Hajos S. Inflammation Research, 2012;61(12):1309-1317.
  9. Combined chemotherapy and ALA-based photodynamic therapy in leukemic murine cells. Diez, B, Ernst G, Teijo MJ, Hajos S, Batlle A, Fukuda H. Leukemia Research; 2012 (36):1179-1184.
  10. Increased hyaluronan levels and decreased dendritic cell activation are associated with tumor invasion in murine lymphoma cell lines. Cordo Russo R; Ernst G.;  Lompardía S; Blanco G.; Álvarez E.;  García. M;  Hajos S.  Immunobiology, 2012;217(9):842-850.
  11. Interaction of CD44 with different forms of AH.It´s role in adhesion and migration of tumor cells.Alaniz L, Cabrera PV, Blanco G, Ernst G, Rimoldi G, Alvarez E, Hajos SE .Cell Adhesion and Communication, 3: 117-130, 2002.
  12. Immunobilogical Characterization of Drug-Resistant Cell lines derived from a murine T cell Leucemia. Caldas Lopez E., Ernst G., Aulicino P., Vansuller S., Blanco G., Hajos S. Clin. Exp. Metastasis 19 (4): 283-290, 2002.
  13. Celomocyte locomotion  in the sipunculanThemistepetricola induced by exogenous and endogenous chemoattractans. Role of CD44-like antigen-HA interaction. Cabrera P., Blanco G., Ernst G., Alvarez E., Cooper E., Hajos S. J. Invertebrat. Phatol., 2: 111-119, 2002.
  14. Chromosome studies of murine T-cell lymphoid leucemia and derived cell lines. Fabris V., Ernst G., Caldas Lopes E., Garcia M., Hajos S., Alvarez E., Merani S. Cancer Genetics and Cytogenetics, 00: 1-6, 2001.
  15. Unión diferencial de ácidohialurónico en líneascelulares CD44+.Posibleimplicancia en la infiltracióntumoral. Ernst G., Caldas Lopes E., Cabrera P., Alvarez E., Hajos S. Medicina 60: 931-939, 2000.
  16. Hepatopulmonary Syndrome and Portopulmonary Hypertension in the Same Patient Ernst G, Grassi F, Chertcoff JF. J ClinMicrobiolBiochemTechnol  2016  2(1): 002-005.
  17. Patient with COPD-Asthma overlap detected by sputum  eosinophilia. Ernst G, Camargo B, Borsini E, Bosio M, Iotti A and Salvado A.  Journal of Medical Cases 10/2015; 6(12):544-546.
  18. Relationship between Body Mass Index, Sex, Age and Respiratory Abnormalities during Sleep G Ernst, A Salvado, M Bosio,  T Decima, F Grassi, F Di Tullio, M Blanco, J Campos,  M Blasco, E Borsini. RAMR 2015; 15 (3): 203-212.
  19. Thoracic Empyema as a Complication of Laparoscopic Cholecysctetomy: Communication of One Case and Review of the Literature. F Grassi,  G Ernst, M Bosio,  C Costabel,  E Di Pietro y G Lyons. RAMR 2015; 15 (3): 240-237.
  20. Prevalence of Obstructive Sleep Apnoea in Patients with Idiopathic Pulmonary Fibrosis
  21. Tabaj G, Visentini D, Malamud P, González Ginestet C, Ernst G, Rando G, SalomonM and       Gramblicka G. Open Access Library Journal, 2015¸ 2: e1645.
  22. Dosaje de unaGlicoproteína Rica en Histidina en el lavadobroncoalveolar de pacientesEnfermedadesIntersticialesDifusas de Pulmón. Ernst G, Dantas E, Caro F, Alberti L, Fernandez M, Borsini E  y Grynblat P. RAMR, 2015;15(2): 131-136.
  23. Red de complejidadcreciente en el diagnóstico de SAHOS Estrategia de transmisión de datos con equipos de nivel III.Borsini E, González C, Koreikis M, Campos J, Bosio M,  Ernst G, Salvado A. RAMR 2015; 15(2): 122-130.
  24. Editorial: Idiopathic Pulmonary Fibrosis. Ernst G. Clinical Anti-Inflammatory & Anti-Allergy Drugs, 2014;1(2): 67.
  25. Idiopathic Pulmonary Fibrosis, Opportunities and Challenges. Ernst G, Borsini E and Salvado S. Clinical Anti-Inflammatory & Anti-Allergy Drugs, 2014,1(2): 95-98.
  26. Ateneo de la sección de patologíadifusa y/o intersticial AAMR: Paciente de 61 años con síndrome de Sjögren y compromisopulmonary. G Tabaj, B Varela, S Quadrelli, M Otaola, J I Enghelmayer, G Olmedo, V Di Boscio, A Werbach, G Ernst. RAMR, 2015,1;85-88.
  27. Biomarcadores en pacientes con Fibrosis IdiopáticaPulmonar. Ernst G, Decima T, Quadrelli S, Borsini E, Canzonieri R, Muryan A  y Salvado A. Fronteras de la Medicina 2015;10(01):0008-0012.
  28. Increased levels of hyaluronic acid in bronchoalveolar lavage from patients with Interstitial Lung Diseases, relationship with lung function and inflammatory cells recruitment. Ernst G, Jancic C, Auteri S, Caro F, Moncalvo J, Galíndez F, Grynblat P, Hajos S. Modern Reseach in Inflammation, 2014 Vol 3, N°2, 27-36.
  29. Significant increase of IL-8 sputum levels intreatment resistant  severe asthma respect to difficult to treat severe asthma patients. Ernst G, Auteri S, Caro F, Colodenco D, Fernandez M, Menga G, Morero J, Neffen H, Schiavi E. Journal of Genetic Syndrome and Gene Therapy 02/2014.
  30. Bronchoalveolar lavage (BAL) is still useful for research studies of Interstitial Lung Diseases. Ernst G, Caro F, Galíndez F, J Rodriguez Moncalvoand  Grynblat P. RAMR 2014;3:221-231.
  31. Utilidad de los componentesdelcuestionario STOP-BANG paraidentificarpacientes con apneas del sueño. Borsini E, Salvado A, Bosio M, Khoury M,  Decima T , Quadrelli S, Ernst G, Chertcoff J. RAMR 2014; 4: 382-403.
  32. Proteinosis Alveolar Pulmonar: UnaPuesta al Día. Tabaj G, Enghelmayer J, Ernst G, Castro Zorrilla L y Scarinci M. RAMR 2014; 3: 282-288.

 

molecular-biology-medicine- Flyer